Medical Properties Trust, Inc.MPWNYSE

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

22 analysts·High coverage

45%

Rating Distribution

Strong Buy

00%

Buy

1045%

Hold

836%

Sell

418%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 4% above analyst consensus — near fair value expected.

Bear Case

$5.00

-4%

Consensus

$5.00

-4%

Bull Case

$5.00

+-4%

Price Range22 analysts

Low

Consensus

High

$5.00

Current Target

Current Price

$5.20

Above Target

$0.20

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.11(2 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+6.40%

EPS+56.19%

FY2028

Rev-0.72%

EPS—

FY2029

Rev+3.06%

EPS—

Earnings Surprises

Beat rate:42%(5/12 quarters)

Avg surprise:+3.3%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Nov 25, 2025Wells Fargo

Medical Properties Trust price target raised to $5 from $4.50 at Wells Fargo

Target:$5.00

-11.5%from $5.65

Mar 11, 2025BNP Paribas

Medical Properties Trust upgraded to Outperform from Neutral at Exane BNP Paribas

Target:$9.00

+57.9%from $5.70

Sep 13, 2024Truist Financial

Medical Properties Trust (MPW) PT Raised to $6 at Truist Securities

Target:$6.00

+7.1%from $5.60

Sep 13, 2024Colliers Securities

Colliers Securities Upgrades Medical Properties Trust (MPW) to Buy

Target:$6.50

+16.1%from $5.60

Sep 12, 2024Mizuho Securities

Mizuho Reiterates Neutral Rating on Medical Properties Trust (MPW)

Target:$7.00

+23.8%from $5.65

Aug 2, 2024Wells Fargo

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 7% Dividend Yields

Target:$7.50

+62.0%from $4.63

Aug 2, 2024Truist Financial

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 7% Dividend Yields

Target:$8.00

+72.8%from $4.63

Jul 1, 2024BNP Paribas

Medical Properties Trust downgraded to Neutral from Outperform at Exane BNP Paribas

Target:$4.00

-2.2%from $4.09

May 29, 2024Truist Financial

Medical Properties Trust (MPW) PT Raised to $5 at Truist Securities

Target:$5.00

+0.4%from $4.98

May 13, 2024RBC Capital

Medical Properties Trust downgraded to Sector Perform from Outperform at RBC Capital

Target:$5.00

-10.4%from $5.58

Apr 17, 2024Deutsche Bank

Medical Properties Trust upgraded to Hold from Sell at Deutsche Bank

Target:$5.00

+8.2%from $4.62

Apr 8, 2024Truist Financial

Medical Properties Trust (MPW) PT Raised to $4.50 at Truist Securities

Target:$4.50

+11.1%from $4.05

Aug 14, 2023RBC Capital

Analyst Foresees Challenges For Medical Properties Trust, Expects 35% Dividend Cut

Target:$10.00

+28.7%from $7.77

Dec 21, 2022Credit Suisse

Credit Suisse Maintains Neutral on Medical Properties Trust, Lowers Price Target to $11

Target:$11.00

+0.6%from $10.93

Sep 22, 2022Raymond James

Raymond James Maintains Strong Buy on Medical Properties Trust, Lowers Price Target to $18

Target:$18.00

+40.6%from $12.80

Sep 16, 2022Deutsche Bank

Deutsche Bank Maintains Hold on Medical Properties Trust, Lowers Price Target to $15

Target:$15.00

+9.6%from $13.69

Jul 29, 2022Mizuho Securities

Mizuho Maintains Buy on Medical Properties Trust, Lowers Price Target to $20

Target:$20.00

+17.4%from $17.03

Jul 15, 2022Raymond James

Raymond James Maintains Strong Buy on Medical Properties Trust, Lowers Price Target to $20

Target:$20.00

+28.6%from $15.55

Jul 13, 2022Deutsche Bank

Deutsche Bank Maintains Hold on Medical Properties Trust, Lowers Price Target to $17

Target:$17.00

+8.4%from $15.68

Jun 30, 2022Jefferies

Jefferies Maintains Hold on Medical Properties Trust, Lowers Price Target to $15

Target:$15.00

-2.5%from $15.38

May 20, 2022RBC Capital

RBC Capital Maintains Outperform on Medical Properties Trust, Lowers Price Target to $22

Target:$22.00

+21.3%from $18.13

May 2, 2022Credit Suisse

Credit Suisse Maintains Outperform on Medical Properties Trust, Lowers Price Target to $23

Target:$23.00

+25.5%from $18.32

Apr 27, 2022Deutsche Bank

Deutsche Bank Maintains Hold on Medical Properties Trust, Lowers Price Target to $20

Target:$20.00

+11.4%from $17.96

Apr 22, 2022Jefferies

Medical Properties Trust downgraded to Hold from Buy at Jefferies

Target:$20.00

-1.6%from $20.33

Nov 23, 2021Barclays

Analysts Offer Insights on Financial Companies: Medical Properties (NYSE: MPW) and Laurentian Bank (Other OTC: LRCDF)

Target:$27.00

+28.5%from $21.01

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance